I-Mab (天境生物) IPO Trading: Tiny Float and Undemanding Valuation
I-Mab (IMAB US) raised USD 104 million at USD 14.0 per ADS, above the mid-point of the IPO price range. I-Mab will start trading today. We have...
433 Views
ECM Weekly (12 Jan 2020) - Jiumaojiu, I-Mab, Phoenix Tree, Burger King India
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. We are...
411 Views
I-Mab (天境生物) IPO: Everest Deal a Valuation Booster
I-Mab launched the book building to raise up to USD 111 million via a listing on NASDAQ. In our previous notes, we covered the company’s key...
434 Views
I-Mab (天境生物) Pre-IPO: Strong Management and Investor Backing with Differentiated Products
I-Mab, a rapidly growing Chinese biotech company, is looking to raise USD100 million via an IPO in the US. The company has a highly differentiated...
469 Views